Standards and methods for assessing the safety and biocompatibility of biomaterials
S.C. Gad, Gad Consulting Services, USA
Abstract:
Evaluation of biocompatability of medical devices and biomaterials to meet regulatory requirement starts with consideration of the ISO-10993 guidance (as currently revised) and relevant local expectations such as the FDA G-95 Memorandum requirements. All of these require one to consider the type and duration of potential patient exposure, then to conduct required testing, and finally to do an integrated risk assessment based on the data collected. This chapter seeks to summarize that effort.
Key words
ISO-10993
FDA G-95-1
USP
biocompatability
foreign body response
innate immunity
9.1 Introduction
Get Characterization of Biomaterials now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
